+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report by Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), Test Type, End-use, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 125 Pages
  • May 2024
  • Region: United States
  • Grand View Research
  • ID: 5976458
Description Jump to:
The U.S. autoimmune disease diagnostics market size is anticipated to reach USD 3.01 billion by 2030, growing at a CAGR of 5.2% from 2024 to 2030. The rising incidence of autoimmune diseases and increasing technological advancements in diagnostic tools and techniques aresignificantly driving the growth of the market.

Increasing awareness about autoimmune diseases among healthcare professionals and patients has led to a higher rate of diagnosis and screening. Public health initiatives, educational campaigns, and advocacy efforts have raised awareness about the signs and symptoms of autoimmune diseases, prompting individuals to seek early diagnosis and treatment. Screening programs aimed at high-risk populations have also contributed to the early detection of autoimmune conditions.

The increasing healthcare expenditure globally, coupled with the growing burden of autoimmune diseases on healthcare systems, has fueled the demand for advanced diagnostic solutions. The government and private organizations are investing in healthcare infrastructure, research, and development to address the challenges posed by autoimmune diseases. This investment drives innovation in diagnostic technologies and promotes access to quality diagnostic services for patients with autoimmune conditions.

U.S. Autoimmune Disease Diagnostics Market Report Highlights

  • Localized autoimmune disease diagnostics type dominated the market with a 66.0% share in 2023 owing to the rising advanced imaging techniques, such as ultrasound, MRI, and PET scans, which allow for detailed visualization of affected tissues or organs.
  • The antinuclear antibody test type segment held the largest market share in 2023 and is anticipated to witness the fastest growth over the forecast period.
  • The hospitals end-use segment dominated the market in 2023 owing to the growingneed for accurate and precise testing methods.
  • In November 2023, Progentec Diagnostics and Mayo Clinic Laboratories announced a strategic partnership to commercialize Progentec’s range of patented biomarker blood tests for the early detection and treatment of autoimmune disorders. The partnership seeks to improve accessibility for patients and clinicians in the United States and a few international markets.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Test Type
1.2.3. End-use
1.2.4. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.2. Volume Price Analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Outlook
2.2.2. Test Type Outlook
2.2.3. End-use Outlook
2.3. Competitive Insights
Chapter 3. U.S. Autoimmune Disease Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Presence of Research Funding Programs
3.2.1.2. Presence of Favorable Government Initiatives
3.2.1.3. Growing Patient Awareness Levels
3.2.1.4. Technological Innovation in the Form of Lab Automation
3.2.2. Market Restraint Analysis
3.2.2.1. Slow Diagnostic Result Turnaround Times and Lack of Skilled
3.3. U.S. Autoimmune Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. U.S. Autoimmune Disease Diagnostics Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Autoimmune Disease Diagnostics Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. U.S. Autoimmune Disease Diagnostics
4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.2. Rheumatoid Arthritis
4.4.1.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.3. Ankylosing Spondylitis Diagnostics
4.4.1.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.4. Systemic Lupus Erythematosus (SLE)
4.4.1.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.1.5. Others
4.4.1.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2. Localized Autoimmune Disease Diagnostics
4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.2. Multiple Sclerosis
4.4.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.3. Type 1 Diabetes
4.4.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.4. Hashimoto's Thyroiditis
4.4.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.5. Idiopathic Thrombocytopenic Purpura
4.4.2.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2.6. Others
4.4.2.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Autoimmune Disease Diagnostics Market: Test Type Estimates & Trend Analysis
5.1. Test Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Autoimmune Disease Diagnostics Market by Test Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Antinuclear Antibody Tests
5.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2. Autoantibody Tests
5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3. C-reactive Protein (CRP)
5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.4. Complete Blood Count (CBC)
5.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.5. Urinalysis
5.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.6. Others
5.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Autoimmune Disease Diagnostics Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Autoimmune Disease Diagnostics Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Hospitals
6.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. Diagnostic Centers
6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Autoimmune Disease Diagnostics Market: Region Estimates & Trend Analysis
7.1. Regional Market Share, 2023 & 2030
7.2. U.S. Autoimmune Disease Diagnostics Market by Region Outlook
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.3.1. West
7.3.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.2. Midwest
7.3.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.3. Northeast
7.3.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.4. Southwest
7.3.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.5. Southeast
7.3.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of Key Distributors and Channel Partners
8.3.2. Key Customers
8.3.3. Key Company Heat Map Analysis, 2023
8.4. Company Profiles
8.4.1. Medtronic
8.4.1.1. Company Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Boston Scientific Corporation
8.4.2.1. Company Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Johnson & Johnson Service Inc. (Ethicon, Inc.)
8.4.3.1. Company Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. AngioDynamics
8.4.4.1. Company Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bioventus Inc. (Misonix Inc.)
8.4.5.1. Company Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. EDAP TMS
8.4.6.1. Company Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Chongqing Haifu Medical Technology Co., Ltd
8.4.7.1. Company Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Mermaid Medical
8.4.8.1. Company Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. HealthTronics, Inc.
8.4.9.1. Company Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. H.S. Hospital Service S.p.A.
8.4.10.1. Company Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 U.S. Autoimmune Disease Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 3 U.S. Autoimmune Disease Diagnostics Market, by Test Type, 2018-2030 (USD Million)
Table 4 U.S. Systemic Autoimmune Disease Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 5 U.S. Localized Autoimmune Disease Diagnostics Market, by Type, 2018-2030 (USD Million)
Table 6 U.S. Autoimmune Disease Diagnostics Market, by End-use, 2018-2030 (USD Million)
Table 7 U.S. Autoimmune Disease Diagnostics Market, by Region, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-chain-based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 U.S. Autoimmune Disease Diagnostics Market: Market Outlook
Figure 9 U.S. Autoimmune Disease Diagnostics Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Related/ancillary Market Outlook
Figure 12 Penetration and Growth Prospect Mapping
Figure 13 U.S. Autoimmune Disease Diagnostics Market Driver Impact
Figure 14 U.S. Autoimmune Disease Diagnostics Market Restraint Impact
Figure 15 U.S. Autoimmune Disease Diagnostics Market: Type Movement Analysis
Figure 16 U.S. Autoimmune Disease Diagnostics Market: Type Outlook and Key Takeaways
Figure 17 Systemic Autoimmune Disease Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 18 Rheumatoid Arthritis Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 19 Ankylosing Spondylitis Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 20 Systemic Lupus Erythematosus (SLE) Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 21 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 22 Localized Autoimmune Disease Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 23 Multiple Sclerosis Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 24 Type 1 Diabetes Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 25 Hashimoto's Thyroiditis Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 26 Idiopathic Thrombocytopenic Purpura Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 27 Others Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 28 U.S. Autoimmune Disease Diagnostics Market: Treatment Movement Analysis
Figure 29 U.S. Autoimmune Disease Diagnostics Market: Treatment Outlook and Key Takeaways
Figure 30 Surgical Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 31 Percutaneous Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 Laparoscopic Ablation Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 U.S. Autoimmune Disease Diagnostics Market: Application Movement Analysis
Figure 34 U.S. Autoimmune Disease Diagnostics Market: Application Outlook and Key Takeaways
Figure 35 Kidney Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 Liver Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 Breast Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 Lung Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Prostate Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Other Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 U.S. Autoimmune Disease Diagnostics Market: Regional Movement Analysis
Figure 42 U.S. Autoimmune Disease Diagnostics Market: Regional Outlook and Key Takeaways
Figure 43 West Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Midwest Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Northeast Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Southwest Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Southeast Market Estimates and Forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Medtronic
  • Boston Scientific Corporation
  • Johnson & Johnson Service Inc. (Ethicon, Inc.)
  • AngioDynamics
  • Bioventus Inc. (Misonix Inc.)
  • EDAP TMS
  • Chongqing Haifu Medical Technology Co., Ltd
  • Mermaid Medical
  • HealthTronics, Inc.
  • H.S. Hospital Service S.p.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages125
PublishedMay 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.11 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.01 Billion
Compound Annual Growth Rate5.2%
Regions CoveredUnited States
No. of Companies Mentioned10

Related Topics

Related Reports

Autoimmune Disease Diagnostics Market by Type, Indication, Test, Product, End User - Global Forecast 2025-2030 - Product Image

Autoimmune Disease Diagnostics Market by Type, Indication, Test, Product, End User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Autoimmune Disease Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Image

Autoimmune Disease Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • 210 Pages
  • Global
From
Autoimmune Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Autoimmune Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
North America Autoimmune Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

North America Autoimmune Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 90 Pages
  • North America
From
Autoimmune Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029 - Product Image

Autoimmune Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029

  • Report
  • 114 Pages
  • Global
From

About the Autoimmune Disease Diagnostics Market

The Autoimmune Disease Diagnostics market is a subset of the Diagnostics industry, which focuses on the detection and diagnosis of autoimmune diseases. Autoimmune diseases are caused by an overactive immune system, which leads to the body attacking its own healthy cells and tissues. Diagnostics for autoimmune diseases involve a variety of tests, such as blood tests, imaging tests, and biopsies. These tests are used to identify the presence of antibodies, which are proteins produced by the immune system in response to an autoimmune disease. The Autoimmune Disease Diagnostics market is driven by the increasing prevalence of autoimmune diseases, as well as advances in technology that have enabled more accurate and efficient diagnosis. Additionally, the increasing availability of diagnostic tests has made them more accessible to patients. Some companies in the Autoimmune Disease Diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Becton Dickinson, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.